Dithioamine reducing agents useful for the reduction of disulfide bonds. The reducing agents of this invention are useful, for example, to reduce disulfide bonds, particularly in proteins, or to prevent the formation of disulfide bonds, particularly in proteins and other biological molecules. Reducing agents of this invention can be employed to regulate protein function in proteins in which a sulfhydryl group is associated with biological activity. Reducing agents of this invention can prevent inactivation of a given protein or enhance activation of a given protein or other biological molecule in vitro and/or in vivo. Reducing agents of this invention can prevent or reduce oxidation of cysteine residues in proteins and prevent the formation of reduced activity protein dimers (or other oligomers). Reducing agents of this invention are useful and suitable for application in a variety of biological applications, particularly as research and synthetic reagents. The invention provides S-acylated dithioamines which can be selectively activated reducing agents by removal of the S-acyl groups enzymatically or chemically. The invention further provides dithiane precursors of thioamino reducing agents. The invention provides dithioamine reducing agents, S-acylated dithioamines and dithianes which are immobilized on surfaces, including among others, glass, quartz, microparticles, nanoparticles and resins.

Dithioamine reducing agents useful for the reduction of disulfide bonds. The reducing agents of this invention are useful, for example, to reduce disulfide bonds, particularly in proteins, or to prevent the formation of disulfide bonds, particularly in proteins and other biological molecules. Reducing agents of this invention can be employed to regulate protein function in proteins in which a sulfhydryl group is associated with biological activity. Reducing agents of this invention can prevent inactivation of a given protein or enhance activation of a given protein or other biological molecule in vitro and/or in vivo. Reducing agents of this invention can prevent or reduce oxidation of cysteine residues in proteins and prevent the formation of reduced activity protein dimers (or other oligomers). Reducing agents of this invention are useful and suitable for application in a variety of biological applications, particularly as research and synthetic reagents. The invention provides S-acylated dithioamines which can be selectively activated reducing agents by removal of the S-acyl groups enzymatically or chemically. The invention further provides dithiane precursors of thioamino reducing agents. The invention provides dithioamine reducing agents, S-acylated dithioamines and dithianes which are immobilized on surfaces, including among others, glass, quartz, microparticles, nanoparticles and resins.

A method for preparing xanthate by a slurry method includes steps of: adding a mixture of dichloromethane and carbon disulfide as a reaction solvent in a slurry reactor, and then adding alcohol and caustic alkali to react with carbon disulfide under less than 1 atm to remove heat released by the reaction by evaporating the solvent; performing vacuum distillation after the reaction to remove the solvent and water, so as to obtain the xanthate; transporting the xanthate to a granulation equipment for granulating, and then drying in a drying equipment to obtain a product. The method is performed in a system formed by a reaction equipment, a solvent recovery equipment, the granulation equipment, and the drying equipment, wherein a main equipment of the reaction system is a slurry reactor. The method has advantages of high efficiency, low energy consumption, good safety, environmental friendliness, convenient operation and the like.

A method for preparing xanthate by a slurry method includes steps of: adding a mixture of dichloromethane and carbon disulfide as a reaction solvent in a slurry reactor, and then adding alcohol and caustic alkali to react with carbon disulfide under less than 1 atm to remove heat released by the reaction by evaporating the solvent; performing vacuum distillation after the reaction to remove the solvent and water, so as to obtain the xanthate; transporting the xanthate to a granulation equipment for granulating, and then drying in a drying equipment to obtain a product. The method is performed in a system formed by a reaction equipment, a solvent recovery equipment, the granulation equipment, and the drying equipment, wherein a main equipment of the reaction system is a slurry reactor. The method has advantages of high efficiency, low energy consumption, good safety, environmental friendliness, convenient operation and the like.

The present invention provides compounds that include a fluorinated allyl xanthate group of formula (I). The invention also relates to a process for making these compounds and the use of said compounds as chain transfer agents or as monomers. The invention relates also to polymers, including copolymers, comprising units deriving from compounds of formula (I).

##STR00001##

The present invention provides compounds that include a fluorinated allyl xanthate group of formula (I). The invention also relates to a process for making these compounds and the use of said compounds as chain transfer agents or as monomers. The invention relates also to polymers, including copolymers, comprising units deriving from compounds of formula (I).

##STR00001##

The present invention relates to stable ionic xanthate compositions in aqueous solution for prolonged periods of time that are useful as collector reagents in the froth flotation process. The stable ionic xanthates of the present invention are dissolved in aqueous solution at their maximum water solubility (28-30%), being highly stable and safe ionic products, preventing the instability and flammability of the solid products which allows safe handling, both for operators in mining work and for the environment.

The present invention provides, in part, di-thioester cationic lipid compounds or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly can be useful for treating various diseases, disorders and conditions, such as those associated with deficiency of one or more proteins.

The present invention provides, in part, di-thioester cationic lipid compounds or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly can be useful for treating various diseases, disorders and conditions, such as those associated with deficiency of one or more proteins.